Clinical Trial

Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic

Completed
View on ClinicalTrials.gov →
Summary
The primary objective of this project is to evaluate the role of patient navigation in promoting timely follow-up of abnormal breast imaging findings in patient populations that have been most severely impacted by the novel coronavirus (COVID-19) pandemic. This project aims to assess the impact of patient navigation as an intervention tool in patient populations that are most at risk for delayed follow-up. The investigators hypothesize that patient navigation services may be an effective way to mitigate the impact of the pandemic by decreasing the risk of a delayed breast cancer diagnosis and promoting timely diagnostic follow-up.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-15
notable Enrollment reduced: 196 -> 126 participants 2026-08-15
notable Primary completion moved earlier: 2026-12 -> 2026-07-27 2026-08-15
minor Completion moved earlier: 2026-12 -> 2026-07-27 2026-08-15
Trial Details
NCT Number NCT05181722
Lead Sponsor Johns Hopkins University
Collaborators: Association of University Radiologists (AUR) - GERRAF
Conditions Breast Cancer
Enrollment 126 participants
Start Date 2022-07-18
Primary Completion 2026-07-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2026-08-14